New technology for combined PET and MRI imaging of brain disorders

Translation and Validation of a Radiofrequency-Penetrable PET insert for Simultaneous PET/MRI imaging of Neurological Disorders

['FUNDING_R01'] · STANFORD UNIVERSITY · NIH-11014975

This study is testing a new imaging tool that combines two types of scans—PET and MRI—to help doctors get a clearer picture of brain conditions like Alzheimer's disease, all while keeping patients safe from extra radiation.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorSTANFORD UNIVERSITY (nih funded)
Locations1 site (STANFORD, UNITED STATES)
Trial IDNIH-11014975 on ClinicalTrials.gov

What this research studies

This research focuses on developing a new type of imaging technology that allows for simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) to better understand neurological disorders, particularly Alzheimer's disease. The innovative PET insert can be integrated into existing MRI machines, providing detailed images without exposing patients to additional radiation. By capturing both anatomical and functional data in one scan, this approach aims to enhance the diagnosis and monitoring of conditions like Alzheimer's. The research involves collaboration with industry partners to ensure the technology meets clinical standards and to gather initial patient data.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related neurological disorders who require imaging for diagnosis or treatment monitoring.

Not a fit: Patients with conditions that do not involve neurological disorders or those who are unable to undergo MRI due to contraindications may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic capabilities and better monitoring of Alzheimer's disease and other neurological disorders.

How similar studies have performed: While PET/MRI technology has been introduced previously, this specific approach using a radiofrequency-penetrable PET insert is novel and aims to address existing barriers to its widespread adoption.

Where this research is happening

STANFORD, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Alzheimer's disease pathology

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.